Kathleen Sebelius's most recent trade in Humacyte Inc was a trade of 80,000 Stock Options (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Humacyte Inc | Kathleen Sebelius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 80,000 | 80,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Kathleen Sebelius | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 08 Apr 2025 | 50,000 | 91,207 | - | 1.3 | 66,000 | Common Stock |
| Humacyte Inc | Kathleen Sebelius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 10 Sep 2024 | 4,521 | 43,910 | - | 4.3 | 19,621 | Common Stock |
| Humacyte Inc | Kathleen Sebelius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 4,521 | 3,979 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Kathleen Sebelius | Director | Sale of securities on an exchange or to another person at price $ 5.41 per share. | 10 Sep 2024 | 3,634 | 40,276 | - | 5.4 | 19,660 | Common Stock |
| Humacyte Inc | Kathleen Sebelius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 2,479 | 6,021 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Kathleen Sebelius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.35 per share. | 10 Sep 2024 | 2,479 | 42,755 | - | 3.4 | 8,305 | Common Stock |
| Humacyte Inc | Kathleen Sebelius | Director | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 10 Sep 2024 | 1,548 | 41,207 | - | 5.4 | 8,344 | Common Stock |
| Humacyte Inc | Kathleen Sebelius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 50,000 | 50,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Kathleen Sebelius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.56 per share. | 13 Jun 2024 | 39,389 | 39,389 | - | 2.6 | 100,836 | Common Stock |
| Humacyte Inc | Kathleen Sebelius | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 39,389 | 0 | - | - | Stock Options (right to buy) | |
| Exact Sciences Corp. | Kathleen Sebelius | Director | 13 Jun 2024 | 7,672 | 32,671 (0%) | 0% | 0 | Common Stock | ||
| Exact Sciences Corp. | Kathleen Sebelius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 6,889 | 31,888 (0%) | 0% | 0 | Common Stock | |
| Humacyte Inc | Kathleen Sebelius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Exact Sciences Corp. | Kathleen Sebelius | Director | 08 Jun 2023 | 3,599 | 24,999 (0%) | 0% | 0 | Common Stock | ||
| Humacyte Inc | Kathleen Sebelius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Exact Sciences Corp. | Kathleen Sebelius | Director | 09 Jun 2022 | 7,523 | 21,400 (0%) | 0% | 0 | Common Stock | ||
| Humacyte Inc | Kathleen Sebelius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Kathleen Sebelius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 39,389 | 39,389 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Kathleen Sebelius | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 17,068 | 17,068 | - | - | Stock Options (right to buy) | |
| Exact Sciences Corp. | Kathleen Sebelius | Director | 30 Jun 2021 | 2,699 | 13,877 (0%) | 0% | 0 | Common Stock | ||
| Exact Sciences Corp. | Kathleen Sebelius | Director | 22 Oct 2020 | 420 | 11,178 (0%) | 0% | 0 | Common Stock | ||
| Exact Sciences Corp. | Kathleen Sebelius | Director | 23 Jul 2020 | 2,558 | 10,758 (0%) | 0% | 0 | Common Stock |